title: High dose methotrexate for ocular lesions of Behçet's disease. Preliminary short-term results.
authors.affiliation: Behçet's Disease Unit, Rheumatology Research Center, Tehran University for Medical Sciences, Shariati Hospital, Tehran, Iran.
authors.forename: F
authors.initials: F
authors.lastname: Davatchi
authors.forename: F
authors.initials: F
authors.lastname: Shahram
authors.forename: H
authors.initials: H
authors.lastname: Chams
authors.forename: A R
authors.initials: AR
authors.lastname: Jamshidi
authors.forename: A
authors.initials: A
authors.lastname: Nadji
authors.forename: C
authors.initials: C
authors.lastname: Chams
authors.forename: M
authors.initials: M
authors.lastname: Akbarian
authors.forename: F
authors.initials: F
authors.lastname: Gharibdoost
mesh_terms: D001528:Behcet Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use*; D031300:Retinal Vasculitis / Q000188:drug therapy* / Q000209:etiology; D013997:Time Factors; D016896:Treatment Outcome; D015866:Uveitis, Posterior / Q000188:drug therapy* / Q000209:etiology; D014792:Visual Acuity / Q000187:drug effects* / Q000502:physiology
chemical_list: D007166:Immunosuppressive Agents; D008727:Methotrexate